A(z) 300360 HR/KN-kód hatályon kívül az EUDR-előkészítés szempontjából.
Medicaments containing any of the following antimalarial active principles: artemisinin (INN) for oral ingestion combined with other pharmaceutical active ingredients, or amodiaquine (INN); artelinic acid or its salts; artenimol (INN); artemotil (INN); artemether (INN); artesunate (INN); chloroquine (INN); dihydroartemisinin (INN); lumefantrine (INN); mefloquine (INN); piperaquine (INN); pyrimethamine (INN) or sulfadoxine (INN), not containing hormones, steroids used as hormones or antibiotics, not in measured doses or put up for retail sale Az indexelt hatálymotor Out of scope eredményt ad erre a kódra. No Annex I scope match was found for this indexed CN code.
Miért ezt a választ adja ez a referenciaoldal.
- Kódleírás
- Medicaments containing any of the following antimalarial active principles: artemisinin (INN) for oral ingestion combined with other pharmaceutical active ingredients, or amodiaquine (INN); artelinic acid or its salts; artenimol (INN); artemotil (INN); artemether (INN); artesunate (INN); chloroquine (INN); dihydroartemisinin (INN); lumefantrine (INN); mefloquine (INN); piperaquine (INN); pyrimethamine (INN) or sulfadoxine (INN), not containing hormones, steroids used as hormones or antibiotics, not in measured doses or put up for retail sale
- I. melléklet szerinti alap
- Nincs közvetlen I. melléklet szerinti bejegyzés
- Forrásalap
- Regulation (EU) 2023/1115 Annex I and CN 2026 index
Szülő-, gyermek- és szomszédos sorok.
A könyvtárnézet a referencianavigációt szolgálja. Használja az ellenőrzőt, ha egy másik kódot műveletként szeretne futtatni.
30pharmaceutical productsout3003medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not in measured doses or put up for retail sale (excl. goods of heading 3002, 3005 or 3006)out30036000medicaments containing any of the following antimalarial active principles: artemisinin (inn) for oral ingestion combined with other pharmaceutical active ingredients, or amodiaquine (inn); artelinic acid or its salts; artenimol (inn); artemotil (inn); artemether (inn); artesunate (inn); chloroquine (inn); dihydroartemisinin (inn); lumefantrine (inn); mefloquine (inn); piperaquine (inn); pyrimethamine (inn) or sulfadoxine (inn), not containing hormones, steroids used as hormones or antibiotics, not in measured doses or put up for retail saleout300310medicaments containing penicillins or derivatives thereof with a penicillanic acid structure, or streptomycins or derivatives thereof, not in measured doses or put up for retail saleout300320medicaments containing antibiotics, not in measured doses or put up for retail sale (excl. medicaments containing penicillins or derivatives thereof with a penicillanic acid structure, or streptomycins or derivatives thereof)out300331medicaments containing insulin, not in measured doses or put up for retail saleout300339medicaments containing hormones or steroids used as hormones, not containing antibiotics, not in measured doses or put up for retail sale (excl. those containing insulin)out300340medicaments containing alkaloids or derivatives thereof, not containing hormones, steroids used as hormones or antibiotics, not in measured doses or put up for retail saleout300341medicaments containing ephedrine or its salts, not containing hormones, steroids used as hormones or antibiotics, not in measured doses or put up for retail saleout
Mit jelent ez az előkészítés szempontjából.
Ez a sor nem közvetlen bizonyítékgyűjtési kiváltó a jelenlegi hatályeredményben.
Regulation (EU) 2023/1115 Annex I — relevant productslekérve: 2026-08-06Commission Delegated Regulation (EU) 2026/2102 amending Annex I to Regulation (EU) 2023/1115lekérve: 2026-09-24Eurostat Comext Combined Nomenclature codelist (CXT_NC v11.0)lekérve: 2026-08-06Eurostat Comext partner country codelist (CXT_FREE_ISO)lekérve: 2026-08-06Eurostat Comext DS-045409 — EU trade since 1988 by HS2-4-6 and CN8lekérve: 2026-08-06Commission Implementing Regulation (EU) 2025/1093 — country benchmarkinglekérve: 2026-08-06Regulation (EU) 2025/2650 amending Regulation (EU) 2023/1115 as regards certain obligations of operators and traderslekérve: 2025-12-26Commission Implementing Regulation (EU) 2026/1565 amending Implementing Regulation (EU) 2024/3084 (EUDR information system)lekérve: 2026-08-08